| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2019/08/13 | 04:12 | Edgar (US Regulatory) | Unknown (sec Staff) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2019/08/09 | 01:03 | Edgar (US Regulatory) | Amended Application for Qualification of Trust Indentures (t-3/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2019/07/20 | 02:51 | Edgar (US Regulatory) | Application for Qualification of Trust Indentures (t-3) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2017/02/15 | 04:00 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2017/02/15 | 00:22 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2017/02/09 | 06:35 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2017/02/01 | 05:43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/13 | 00:42 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/10 | 06:07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/09 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/05 | 20:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/02 | 07:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/02 | 07:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/12/01 | 05:32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 07:08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:23 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 06:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/30 | 02:10 | GlobeNewswire Inc. | Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc. | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/18 | 06:15 | GlobeNewswire Inc. | Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (H... | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/16 | 20:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/08 | 07:40 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/05 | 06:34 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/05 | 05:03 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 2016/11/04 | 06:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |